These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32948569)

  • 21. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
    Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
    BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
    Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
    Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania.
    Kahesa C; Kjaer SK; Ngoma T; Mwaiselage J; Dartell M; Iftner T; Rasch V
    BMC Public Health; 2012 Dec; 12():1055. PubMed ID: 23216752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incident detection of human papillomavirus - a prospective follow-up study among Tanzanian women with a focus on HIV status.
    Mchome B; Linde DS; Manongi R; Waldstroem M; Lftner T; Wu C; Mwaisalage J; Rasch V; Kjaer SK
    Int J Infect Dis; 2021 Sep; 110():165-170. PubMed ID: 34252573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
    BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status.
    Olesen TB; Iftner T; Mwaiselage J; Kahesa C; Rasch V; Ngoma T; Munk C; Kjaer SK
    Sex Transm Dis; 2013 Jul; 40(7):592-8. PubMed ID: 23965778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
    Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
    Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
    Bhatta MP; Johnson DC; Lama M; Aryal S; Lhaki P; Shrestha S
    BMC Infect Dis; 2017 Jan; 17(1):73. PubMed ID: 28088173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study.
    Hall MT; Smith MA; Simms KT; Barnabas RV; Canfell K; Murray JM
    PLoS One; 2020; 15(5):e0231388. PubMed ID: 32374729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
    Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.